Patient Leaflet Updated 07-Jul-2026 | Aurobindo Pharma - Milpharm Ltd.
Risedronate sodium 30 mg film-coated tablets
Risedronate sodium 30 mg film-coated tablets
risedronate sodium
The name of your medicine is Risedronate sodium 30 mg film-coated tablets (referred to as Risedronate tablets throughout this leaflet).
1. What Risedronate tablets is and what it is used for
2. What you need to know before you take Risedronate tablets
3. How to take Risedronate tablets
4. Possible side effects
5. How to store Risedronate tablets
6. Contents of the pack and other information
Risedronate tablets belongs to a group of non-hormonal medicines called bisphosphonates which are used to treat bone diseases. It works directly on your bones to make them stronger and therefore less likely to break.
Bone is a living tissue. Old bone is constantly removed from your skeleton and replaced with new bone.
Paget’s disease occurs when this process, called remodeling, happens too quickly and in a disordered way. The new bone that is produced is weaker than normal and the affected bones may become enlarged, painful and may fracture. Risedronate tablets changes the bone remodeling process back to normal, returning the strength to the bone structure.
Treatment of Paget’s disease of the bone (osteitis deformans).
Talk to your doctor or pharmacist before taking Risedronate tablets.
Your doctor will advise you on what to do when taking Risedronate tablets if you have any of the above.
Risedronate sodium is not recommended for use in children and adolescents below age 18 due to insufficient data on safety and efficacy.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Medicines containing one of the following lessen the effect of Risedronate tablets if taken at the same time:
Take these medicines at least 30 minutes after your Risedronate tablets.
It is very important that you do NOT take your Risedronate tablets with food or drinks (other than plain water) so that it can work properly. In particular do not take this medicine at the same time as dairy products (such as milk) as they contain calcium (see section 2, “Other medicines and Risedronate tablets”).
Take food and drinks (other than plain water) at least 30 minutes after your Risedronate tablets.
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Do not take Risedronate tablets if you may be pregnant, are pregnant or planning to become pregnant (see section 2, “Do not take Risedronate tablets”). The potential risk associated with the use of risedronate sodium (active substance in Risedronate tablets) in pregnant women is unknown.
Do not take Risedronate tablets if you are breast-feeding (see section 2, “Do not take Risedronate tablets”).
Risedronate tablets is not known to affect your ability to drive and use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
This medicine contains less than 1 mmol sodium (23 mg) per film-coated tablet, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is:
Take one Risedronate tablets (30 mg of risedronate sodium) once a day.
The recommended treatment duration is usually 2 months.
It is best to take your Risedronate tablets at least 30 minutes before the first food, drink (other than plain water) or other medicine of the day.
If in particular instance you are unable to take your Risedronate tablets at this time, you may take it on an empty stomach, at the same time every day, in one of the following ways:
Between meals: at least 2 hours after your last food, drink (other than plain water) or other medicine. Do not eat or drink (other than plain water) for 2 hours after taking the tablet.
In the evening: at least 2 hours after your last food, drink (other than plain water) or other medicine of the day. Risedronate tablets should be taken at least 30 minutes before going to bed.
Your doctor will tell you if you need calcium and vitamin supplements, if you are not taking enough from your diet.
If you or somebody else has accidentally taken more Risedronate tablets than prescribed, drink one full glass of milk and seek medical attention.
If you have forgotten to take your tablet at your regular time, you can take it at the next possible time according to the instruction above (i.e. before breakfast, between meals, or in the evening).
Do not take a double dose to make up for a forgotten dose.
Please talk to your doctor if you consider stopping treatment before the end of prescribed duration
If you have any further questions on the use of this medicine, ask your doctor or pharmacist
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Risedronate tablets and contact a doctor immediately if you experience any of the following:
Tell your doctor promptly if you experience the following side effects:
However in clinical studies the other side effects that were observed were usually mild and did not cause the patient to stop taking their tablets.
Common: may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
During post-marketing experience, the following have been reported (unknown frequency);
Rarely, at the beginning of treatment, a patient’s blood calcium and phosphate levels may fall. These changes are usually small and cause no symptoms.
The additional following adverse events has also been observed in a clinical study in patients with Paget’s disease: vision difficulties, breathing difficulties, coughing, inflammation of the large intestine, surface of the eye damage, cramps, dizziness, dryness of the eye, flu-like symptoms, muscle weakness, abnormal growth of cells, a frequent need to pass water at night, unusual lumps or swellings, chest pain, rash, runny nose, ringing in the ears and weight loss.
Unusual fracture of the thigh bone particularly in patients on long-term treatment for osteoporosis may occur rarely. Contact your doctor if you experience pain, weakness or discomfort in your thigh, hip or groin as this may be an early indication of a possible fracture of the thigh bone.
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is risedronate sodium. Each film-coated tablet contains 30 mg risedronate sodium (equivalent to 27.8 mg risedronic acid).
The other ingredients are:
Tablet core: Lactose monohydrate, crospovidone, hydroxy propyl cellulose, magnesium stearate and cellulose microcrystalline.
Film coating: Hypromellose, titanium dioxide (E171), macrogol 400, hydroxy propyl cellulose.
Film-coated tablet.
White to off-white coloured, circular shaped film coated biconvex tablets debossed with ‘L’ on one side and ‘30’ on the other side.
Transparent PVC / PE / PVdC / Aluminium blisters in a cardboard box, Packs of 14 or 28 tablets.
Not all pack sizes may be marketed.
or
This leaflet was last revised in 10/2025.
P1540245
Milpharm Limited, 1 Roundwood Avenue, Stockley Park, Uxbridge, UB11 1AF, UK
+ 44 (0)208 845 8811
+44 (0)208 845 8811
http://www.aurobindo.com
+44 (0)208 845 8795